Bioactivity of dressings based on platelet-rich plasma and Platelet-rich fibrin for tissue regeneration in animal model.

João Abel Sá-Oliveira, Monique Vieira Geraldo, Milena Marques, Rafael Messias Luiz, Filipe Krasinski Cestari, Ingrid Nascimento Lima, Thayná Cristine De Souza, Ana Carla Zarpelon-Schutz, Kádima Nayara Teixeira
Author Information
  1. João Abel Sá-Oliveira: Programa Multicêntrico de Pós-graduação em Bioquímica e Biologia Molecular - Setor Palotina, Universidade Federal do Paraná, Palotina 85950-000, Paraná, Brazil.
  2. Monique Vieira Geraldo: Campus Toledo, Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  3. Milena Marques: Campus Toledo, Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  4. Rafael Messias Luiz: Campus Toledo, Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  5. Filipe Krasinski Cestari: Patologia, Laboratório Prevenção Patologia, Cascavel 85810-040, Paraná, Brazil.
  6. Ingrid Nascimento Lima: Campus Toledo, Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  7. Thayná Cristine De Souza: Medicina-Campus Toledo, UFPR - Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  8. Ana Carla Zarpelon-Schutz: Campus Toledo, Universidade Federal do Paraná, Toledo 85919-899, Paraná, Brazil.
  9. Kádima Nayara Teixeira: Programa Multicêntrico de Pós-graduação em Bioquímica e Biologia Molecular - Setor Palotina, Universidade Federal do Paraná, Palotina 85950-000, Paraná, Brazil.

Abstract

BACKGROUND: Skin wounds are common injuries that affect quality of life and incur high costs. A considerable portion of healthcare resources in Western countries is allocated to wound treatment, mainly using mechanical, biological, or artificial dressings. Biological and artificial dressings, such as hydrogels, are preferred for their biocompatibility. Platelet concentrates, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), stand out for accelerating tissue repair and minimizing risks of allergies and rejection. This study developed PRF and PRP-based dressings to treat skin wounds in an animal model, evaluating their functionality and efficiency in accelerating the tissue repair process.
AIM: To develop wound dressings based on platelet concentrates and evaluating their efficiency in treating skin wounds in Wistar rats.
METHODS: Wistar rats, both male and female, were subjected to the creation of a skin wound, distributed into groups ( = 64/group), and treated with Carbopol (negative control); PRP + Carbopol; PRF + Carbopol; or PRF + CaCl + Carbopol, on days zero (D0), D3, D7, D14, and D21. PRP and PRF were obtained only from male rats. On D3, D7, D14, and D21, the wounds were analyzed for area, contraction rate, and histopathology of the tissue repair process.
RESULTS: The PRF-based dressing was more effective in accelerating wound closure early in the tissue repair process (up to D7), while PRF + CaCl seemed to delay the process, as wound closure was not complete by D21. Regarding macroscopic parameters, animals treated with PRF + CaCl showed significantly more crusting (necrosis) early in the repair process (D3). In terms of histopathological parameters, the PRF group exhibited significant collagenization at the later stages of the repair process (D14 and D21). By D21, fibroblast proliferation and inflammatory infiltration were higher in the PRP group. Animals treated with PRF + CaCl experienced a more pronounced inflammatory response up to D7, which diminished from D14 onwards.
CONCLUSION: The PRF-based dressing was effective in accelerating the closure of cutaneous wounds in Wistar rats early in the process and in aiding tissue repair at the later stages.

Keywords

References

  1. Biomed Res Int. 2016;2016:6591717 [PMID: 27672658]
  2. J Conserv Dent. 2019 Jan-Feb;22(1):23-27 [PMID: 30820078]
  3. Adv Wound Care (New Rochelle). 2021 May;10(5):281-292 [PMID: 33733885]
  4. Burns Trauma. 2020 Aug 14;8:tkaa028 [PMID: 32821743]
  5. J Clin Med. 2023 Jun 07;12(12): [PMID: 37373585]
  6. Adv Drug Deliv Rev. 2019 Jun;146:209-239 [PMID: 30605737]
  7. J Wound Ostomy Continence Nurs. 2010 May-Jun;37(3):253-9 [PMID: 20386331]
  8. Biomedicines. 2023 Jul 06;11(7): [PMID: 37509560]
  9. Dent Clin North Am. 2020 Apr;64(2):291-303 [PMID: 32111269]
  10. Int J Mol Sci. 2018 Oct 18;19(10): [PMID: 30340330]
  11. Acta Histochem. 2011 May;113(3):231-3 [PMID: 20188402]
  12. Acta Cir Bras. 2006;21 Suppl 3:55-65 [PMID: 17293938]
  13. Biology (Basel). 2021 Apr 10;10(4): [PMID: 33920204]
  14. J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1266-S1267 [PMID: 35017968]
  15. Int J Environ Res Public Health. 2021 Aug 04;18(16): [PMID: 34443998]
  16. Br J Sports Med. 2015 Jul;49(14):957-60 [PMID: 23770705]
  17. Biomedicines. 2021 Mar 04;9(3): [PMID: 33806471]
  18. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e37-44 [PMID: 16504849]
  19. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Nov;108(5):707-13 [PMID: 19836723]
  20. J Invest Dermatol. 2007 Mar;127(3):514-25 [PMID: 17299434]
  21. Rev Esc Enferm USP. 2020 Sep 21;54:e03582 [PMID: 32965438]
  22. J Vet Dent. 2019 Jun;36(2):109-123 [PMID: 31662059]
  23. Diagnostics (Basel). 2022 Oct 03;12(10): [PMID: 36292091]
  24. J Clin Laser Med Surg. 2003 Oct;21(5):249-58 [PMID: 14651792]
  25. Front Immunol. 2022 Mar 01;13:789274 [PMID: 35300324]
  26. Front Physiol. 2022 Nov 18;13:1059369 [PMID: 36467702]
  27. J Tissue Eng Regen Med. 2016 May;10(5):428-36 [PMID: 23723151]

Word Cloud

Created with Highcharts 10.0.0PRFrepairprocess+woundtissuewoundsdressingsD21PRPacceleratingratsCarbopolCaClD7D14platelet-richplasmafibrinskinmodelWistartreatedD3closureearlyPlatelet-richSkinartificialconcentratesanimalevaluatingefficiencybasedmalePRF-baseddressingeffectiveparametersgrouplaterstagesinflammatoryBACKGROUND:commoninjuriesaffectqualitylifeincurhighcostsconsiderableportionhealthcareresourcesWesterncountriesallocatedtreatmentmainlyusingmechanicalbiologicalBiologicalhydrogelspreferredbiocompatibilityPlateletstandminimizingrisksallergiesrejectionstudydevelopedPRP-basedtreatfunctionalityAIM:developplatelettreatingMETHODS:femalesubjectedcreationdistributedgroups=64/groupnegativecontroldayszeroD0obtainedanalyzedareacontractionratehistopathologyRESULTS:seemeddelaycompleteRegardingmacroscopicanimalsshowedsignificantlycrustingnecrosistermshistopathologicalexhibitedsignificantcollagenizationfibroblastproliferationinfiltrationhigherAnimalsexperiencedpronouncedresponsediminishedonwardsCONCLUSION:cutaneousaidingBioactivityregenerationMurineTissue

Similar Articles

Cited By

No available data.